TY - JOUR
KW - Humans
KW - *Idiopathic Pulmonary Fibrosis/epidemiology/mortality/diagnosis
KW - Male
KW - Female
KW - Aged
KW - *Comorbidity
KW - Middle Aged
KW - *Pulmonary Disease, Chronic Obstructive/epidemiology/diagnosis/mortality
KW - Prevalence
KW - Aged, 80 and over
KW - Cohort Studies
KW - Incidence
KW - chronic obstructive pulmonary disease
KW - Comorbidities
KW - Idiopathic pulmonary fibrosis
AU - B. Ozaltin
AU - R. Chapman
AU - M. Arfeen
AU - N. Fitzpatick
AU - H. Hemingway
AU - K. Direk
AU - J. Jacob
AD - Satsuma Lab, Centre for Medical Image Computing, UCL, London, UK.
UCL Respiratory, UCL, London, UK.
UCL Institute of Health Informatics, UCL, London, UK.
Imperial Clinical Trials Unit, Imperial College London, London, UK.
Satsuma Lab, Centre for Medical Image Computing, UCL, London, UK. j.jacob@ucl.ac.uk.
UCL Respiratory, UCL, London, UK. j.jacob@ucl.ac.uk.
AN - 38898447
BT - Respir Res
C2 - PMC11186192
DO - 10.1186/s12931-024-02875-2
DP - NLM
ET - 2024/06/20
LA - eng
M1 - 1
N1 - 1465-993x
Ozaltin, Burcu
Chapman, Robert
Arfeen, Muhammad Qummer Ul
Fitzpatick, Natalie
Hemingway, Harry
Direk, Kenan
Jacob, Joseph
[209553/Z/17/Z]/WT_/Wellcome Trust/United Kingdom
Journal Article
Observational Study
England
Respir Res. 2024 Jun 19;25(1):249. doi: 10.1186/s12931-024-02875-2.
PY - 2024
SN - 1465-9921 (Print)
1465-9921
EP - 249
T2 - Respir Res
TI - Delineating excess comorbidities in idiopathic pulmonary fibrosis: an observational study
VL - 25
ER -